Ten-year outcomes of I125 low-dose-rate brachytherapy for clinically localized prostate cancer: a single-institution experience in Japan
详细信息 查看全文
- 作者：Narihiko Hayashi ; Koji Izumi ; Futoshi Sano ; Yasuhide Miyoshi…
- 关键词：Prostate cancer ; Brachytherapy ; Localized ; Monotherapy ; Asian
- 刊名：World Journal of Urology
- 出版年：2015
- 出版时间：October 2015
- 年：2015
- 卷：33
- 期：10
- 页码：1519-1526
- 全文大小：525 KB
- 参考文献：1.Holm HH, Gammelgaard J (1981) Ultrasonically guided precise needle placement in the prostate and the seminal vesicles. J Urol 125(3):385鈥?87PubMed
2.Cooperberg MR, Broering JM, Carroll PR et al (2010) Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 28(7):1117鈥?123PubMed Central CrossRef PubMed
3.Wilt TJ, Brawer MK, Jones KM et al (2012) Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367:203鈥?13PubMed Central CrossRef PubMed
4.Schroeck FR, Krupski TL, Sun L et al (2008) Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol 54(4):785鈥?93CrossRef PubMed
5.Gwede CK, Pow-Sang J, Seigne J et al (2006) Treatment decision making strategies and influences in patients with localized prostate cancer. Cancer 107:620鈥?30CrossRef
6.Williams S, Chiong E, Lojanapiwat B et al (2013) Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol 14(12):e524鈥揺534CrossRef PubMed
7.Walz J, Gallina A, Saad F et al (2007) A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 25(24):3576鈥?581CrossRef PubMed
8.Grimm P, Billiet I, Bostwick D et al (2012) Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 109(suppl 1):22鈥?9CrossRef PubMed
9.Morris WJ, Keyes M, Spadinger I et al (2013) Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer. Cancer 119(8):1537鈥?546CrossRef PubMed
10.Jones CU, Hunt D, McGowan DG et al (2011) Radiotherapy and short term androgen deprivation for localized prostate cancer. N Engl J Med 365(2):107鈥?18CrossRef PubMed
11.Cooperberg MR, Hinotsu S, Namiki M et al (2009) Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy. J Clin Oncol 27(26):4306鈥?313PubMed Central CrossRef PubMed
12.Akaza H, Carroll P, Cooperberg MR, Hinotsu S et al (2012) Fifth joint meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its management. Jpn J Clin Oncol 42(3):226鈥?36CrossRef PubMed
13.Ueno S, Namiki M, Fukagai T et al (2006) Efficacy of primary hormonal therapy for patients with localized and locally advanced prostate cancer: a retrospective multicenter study. Int J Urol 13:1494鈥?500CrossRef PubMed
14.Williams S, Chiong E, Lojanapiwat B et al (2013) Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013. Lancet Oncol 14(12):e524鈥揺534CrossRef PubMed
15.Taira AV, Merrick G, Butler WM et al (2011) Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapy. Int J Radiat Oncol Biol Phys 79:1336鈥?342CrossRef PubMed
16.Potters L, Morgenstern C, Calugary E et al (2008) 12-Year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 179:S20鈥揝24CrossRef PubMed
17.Zelefsky MJ, Kuban DA, Levy LB et al (2007) Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J Radiat Oncol Biol Phys 67:327鈥?33CrossRef PubMed
18.Marshall RA, Buckstein M, Stone NN et al (2014) Treatment outcomes and morbidity following definitive brachytherapy with or without external beam radiation for the treatment of localized prostate cancer: 20-year experience at Mount Sinai Medical Center. Urol Oncol 32(1):38.e1鈥?8.e7CrossRef
19.D鈥橝mico AV, Moran BJ, Braccioforte MH et al (2009) Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease. J Clin Oncol 27(24):3923鈥?938CrossRef PubMed
20.Konaka H, Egawa S, Saito S et al (2012) Tri-modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial. BMC Cancer 22(12):110CrossRef
21.Kibel AS, Ciezki JP, Klein EA et al (2012) Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol 187:1259鈥?265CrossRef PubMed
22.Cooperberg MR, Vickers AJ, Broering JM, Carroll PR et al (2010) Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer 116:5226鈥?234PubMed Central CrossRef PubMed
23.Kimura T, Kido M, Miki K et al (2014) Mid-term outcome of permanent prostate iodine-125 brachytherapy in Japanese patients. Int J Urol 21(5):473鈥?78CrossRef PubMed
24.Zelefsky MJ, Pei X, Teslova T et al (2012) Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment intervention. BJU Int 110(11):1696鈥?701CrossRef PubMed
25.Ikegami N, Yoo BK, Hashimoto H et al (2011) Japanese universal health coverage: evolution, achievements, and challenges. Lancet 378:1106鈥?115CrossRef PubMed - 作者单位：Narihiko Hayashi (1)
Koji Izumi (1)
Futoshi Sano (1)
Yasuhide Miyoshi (1)
Hiroji Uemura (1)
Takeo Kasuya (2)
Akiko Mukai (2)
Masayuki Hata (2)
Tomio Inoue (2)
1. Department of Urology, School of Medicine, Yokohama City University, Yokohama, Japan
2. Department of Radiology, School of Medicine, Yokohama City University, Yokohama, Japan - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Urology and Andrology
Nephrology
Oncology - 出版者：Springer Berlin / Heidelberg
- ISSN：1433-8726
文摘
Purpose To report 10-year outcomes of patients treated with I125 low-dose-rate brachytherapy (BT) for clinically localized prostate cancer.